MN HF3786

Expands the definition of "intractable pain" to explicitly include noncancer pain, rare diseases, orphan diseases, severe injuries, and conditions requiring palliative or hospice care, in addition to cancer and sickle cell disease.

Creates new evaluation criteria for nonterminally ill patients with intractable pain requiring only a diagnosis from the treating physician plus one specialist in pain medicine or the relevant body system, rather than requiring additional physician consultations.

Prohibits physicians, advanced practice registered nurses, and physician assistants from being disciplined solely for prescribing opioid dosages exceeding morphine milligram equivalent guidelines if the patient is stable, compliant, and experiencing no serious harm.

Prevents pharmacists and pharmacy benefit managers from refusing to fill opioid prescriptions based solely on exceeding morphine milligram equivalent thresholds, and prohibits automatic dosage tapering to meet predetermined opioid limits.

Requires written patient-provider agreements before treating intractable pain, with annual reviews and updates, documenting risks, expectations, and responsibilities; exceptions made for emergency and inpatient hospital settings.